SCHEMBL7119646

SCHEMBL7119646

Oc1c(Br)cc(Cl)cc1Br

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ERN1 O75460 2/20 0.60
TSHR P16473 5/20 0.58
CYP3A4 P08684 4/20 0.58
TDP1 Q9NUW8 2/20 0.58
ALDH1A1 P00352 3/20 0.50
RECQL P46063 3/20 0.50
HSD17B10 Q99714 3/20 0.50
TTR P02766 3/20 0.46
MEN1 O00255 3/20 0.46
KMT2A Q03164 3/20 0.46
HPGD P15428 2/20 0.46
ALOX15 P16050 2/20 0.46
ALOX12 P18054 2/20 0.46
CASP1 P29466 2/20 0.46
HIF1A Q16665 2/20 0.46
ALB P02768 1/20 0.46
CA1 P00915 2/20 0.46
CA2 P00918 2/20 0.46
CA4 P22748 1/20 0.46
CA6 P23280 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2417306 0.88 TSHR (0.68) ERN1TSHRCYP3A4TDP1ALDH1A1
SCHEMBL264625 0.86 ERN1 (0.54) ERN1TSHRCYP3A4TDP1ALDH1A1
SCHEMBL29106822 0.86 GABRA1 (0.56) ERN1TSHRCYP3A4TDP1ALDH1A1
SCHEMBL13331594 0.83 ERN1 (0.52) ERN1TSHRCYP3A4TDP1ALDH1A1
SCHEMBL9148389 0.82 ERN1 (0.50) ERN1TSHRCYP3A4TDP1ALDH1A1
SCHEMBL9051365 0.82 ERN1 (0.50) ERN1TSHRCYP3A4TDP1ALDH1A1
SCHEMBL1163160 0.82 ERN1 (0.50) ERN1TSHRCYP3A4TDP1ALDH1A1
SCHEMBL14151513 0.82 ERN1 (0.50) ERN1TSHRCYP3A4TDP1ALDH1A1
SCHEMBL3355916 0.82 ERN1 (0.50) ERN1TSHRCYP3A4TDP1ALDH1A1
SCHEMBL582239 0.80 TSHR (0.68) ERN1TSHRCYP3A4TDP1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105693032-B A kind of bio-pharmaceuticals factory organic wastewater treating system and its processing method 江苏建筑职业技术学院 2018-05-25 CN claimed
CN-106124646-A A kind of detect the method for polarity phenol chloro/bromo disinfection byproduct (DBP) in water 南京大学 2016-11-16 CN claimed
CN-105693032-A Biological pharmaceutical factory organic wastewater treatment system and treatment method 江苏建筑职业技术学院 2016-06-22 CN claimed
US-6576739-B2 Conversion of the hindered bisphenol to the corresponding bischloroformate and subsequent treatment with an amine catalyst and an aqueous base to effect polymerization by hydrolysis and condenstation of bischloroformate groups GENERAL ELECTRIC COMPANY 2003-06-10 US claimed
JP-59013793-A None JP disclosed
CN-117886760-A Synthesis method of 3- (5-fluoropyrimidine-2-yl) -2-methoxy aniline 爱斯特(成都)生物制药股份有限公司 2024-04-16 CN disclosed
US-11440989-B2 Application of Mannich base in flame-retardant polyurethane material JIAHUA SCIENCE & TECHNOLOGY DEVELOPMENT (SHANGHAI) LTD. (CN) 2022-09-13 US disclosed
US-11401375-B2 Flame-retardant polyether polyol as well as preparation method and application thereof JIAHUA SCIENCE & TECHNOLOGY DEVELOPMENT (SHANGHAI) LTD. (CN) 2022-08-02 US disclosed
US-20210317134-A1 UBIQUITIN-SPECIFIC-PROCESSING PROTEASE 7 (USP7) MODULATORS AND USES THEREOF RAPT THERAPEUTICS INC (US) 2021-10-14 US disclosed
US-20200283562-A1 APPLICATION OF MANNICH BASE IN FLAME-RETARDANT POLYURETHANE MATERIAL JIAHUA CHEMICALS INC. (CN) 2020-09-10 US disclosed
US-20200283573-A1 FLAME-RETARDANT POLYETHER POLYOL AS WELL AS PREPARATION METHOD AND APPLICATION THEREOF JIAHUA SCIENCE & TECHNOLOGY DEVELOPMENT (SHANGHAI) LTD. (CN) 2020-09-10 US disclosed
US-10722514-B2 Ubiquitin-specific-processing protease 7 (USP7) modulators and uses thereof RAPT THERAPEUTICS, INC. (US) 2020-07-28 US disclosed
US-4913821-A Method for the determination of phenols in water THE DOW CHEMICAL COMPANY (US) 1990-04-03 US disclosed
US-4822804-A 5,6,7,-trinor-4,8-inter-m-phenylene 2-nor PGI2 derivatives and anti-ulcer, anti-thrombotic and anti-hypertensive pharmaceutical compositions containing them TORAY INDUSTRIES, INC. (JP) 1989-04-18 US disclosed
US-4564620-A 5,6,7,-Trinor-4,8-inter-m-phenylene PGI2 derivatives and anti-ulcer, anti-thrombotic and anti-hypertensive pharmaceutical compositions containing them TORAY INDUSTRIES, INC. (JP) 1986-01-14 US disclosed
EP-0060640-B1 5,6,7-TRINOR-4,8-INTER-M-PHENYLENE PGI DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM TORAY INDUSTRIES, INC. (JP) 1985-11-13 EP disclosed
JP-S5913793-A ORGANIC PHOSPHORIC ESTER COMPOUND, ITS PREPARATION, INSECTICIDE AND ACARICIDE CONTAINING IT AS ACTIVE INGREDIENT KANESHO KK 1984-01-24 JP disclosed
EP-0060640-A1 5,6,7-Trinor-4,8-inter-m-phenylene PGI derivatives and pharmaceutical compositions containing them TORAY INDUSTRIES, INC. (JP) 1982-09-22 EP disclosed
US-4313977-A FORMING WATER INSOLUBLE ORGANIC SALT OF PHENOL THE DOW CHEMICAL COMPANY (US) 1982-02-02 US disclosed
US-4010252-A POLYQUATERNARY AMMONIUM COMPOUND, DEODORANTS COLGATE-PALMOLIVE COMPANY (US) 1977-03-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11440989-B2 Application of Mannich base in flame-retardant polyurethane material FBL, HNRNPUL2, HNRNPUL1 ERN1 660/4885TSHR 2890/4885CYP3A4 2597/4885
US-10722514-B2 Ubiquitin-specific-processing protease 7 (USP7) modulators and uses thereof USP7, SENP7, USP8 ERN1 459/4885TSHR 3825/4885CYP3A4 3186/4885
US-20210317134-A1 UBIQUITIN-SPECIFIC-PROCESSING PROTEASE 7 (USP7) MODULATORS AND USES THEREOF USP7, SENP7, USP8 ERN1 459/4885TSHR 3825/4885CYP3A4 3186/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.